Loading clinical trials...
Loading clinical trials...
Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms: Phase I and Phase II Clinical Trial
Conditions
Interventions
Irreversible electroporation (IRE)
NanoKnife
Locations
1
China
Biological treatment center in Fuda cancer hospital
Guangzhou, Guangdong, China
Start Date
January 1, 2015
Primary Completion Date
December 1, 2020
Completion Date
January 1, 2021
Last Updated
September 5, 2021
NCT00576134
NCT00941135
Lead Sponsor
Fuda Cancer Hospital, Guangzhou
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions